NSpine 3rd Combined Cadaveric & Live Tissue Training: 20 - 23 July 2023

NSpine returns to IRCAD for the 3rd Combined Cadaveric and Live Tissue Training Course 20-23 July 2023 – register now!

Building on the success of the 2021 and 2022 events NSpine will again offer an exceptional surgical training opportunity at the outstanding Strasbourg IRCAD institute with parallel surgical training modules:

  • 1A – Spine Endoscopy (Cadaveric/ Model)
  • 1B – Expert Spine Endoscopy and Complications (Live Tissue)
  • 2 – Advanced Spine Tumour Reconstructive Techniques (en-bloc surgery) (Cadaveric / Model)
  • 3 – Anterior Lumbar Access (ALIF / TDR / OLIF) and Complications Management (Cadaveric / Live Tissue)
  • 4 – Expert Anterior Spine Access Complications Management (Live Tissue)
  • 5 – Lateral (XLIF / X-ALIF) Reconstruction and Complications Management (Cadaver / Model / Live Tissue)
  • 6 – Single Position Prone / Lateral & Posterior Techniques (Cadaver)
  • 7 – Posterior Thoracic Spine – Pelvis Instrumentation, Osteotomy and Reconstruction Techniques (Cadaver)
  • 8 – Advanced Anterior Scoliosis Techniques including VBT and Complications Management (Cadaver / Model / Live Tissue)
  • 9 – Paediatric Deformity Training (EOS / congenital / AIS) (Model)
  • 10 – Intraoperative Neuromonitoring (Live Tissue)
  • 11 – Posterior Cervical Instrumentation and Decompression (Cadaver / Model)
  • 12 – Anterior Cervical Discectomy and Corpectomy (Cadaver / Model)
  • 13 – Advanced Anterior and Lateral Cervical Dissection (C0-T4)

International faculty of highest repute will again be working with delegates in a 1:2 or 1:1 ratio providing expert surgical tuition.

17 tables are available with limited places to maintain training quality.

Industry partner enquiries welcome.

COVID Travel Rules

For up to date information on travelling to France – please click here.

The below information is as it stands currently – Last updated January 2023.

The rules previously applied to travellers to France no longer apply effective from 1 August 2022:

  • Travellers are now exempt from any formalities prior to entry into France, be it in mainland France or overseas, and no longer required to present a health pass, regardless of the country or place of departure;
  • Justification of travel (the “compelling reason”) is no longer required;
  • Travellers are no longer required to present a sworn statement of non-contamination and an undertaking to undergo an antigen test or screening upon arrival in the country.

The same applies to travel between mainland France and each of the overseas territories. Similarly, the French authorities no longer require any justification for outgoing travel from France, be it from mainland France or overseas, or any exit clearance to travel to another country.

However, foreign countries may continue to apply specific entry measures and formalities.

 

For passengers travelling from China:

Wearing a mask is mandatory on flights from China effective 1 January 2023 for all passengers aged six years or older.

As from 5 January 2023, all passengers aged eleven years or older, travelling from China on a direct or stopover flight, must present the airline with the following before boarding:

  • a negative antigen or PCR test result dated less than 48 hours;
  • a sworn statement confirming that they:
    • have no symptoms of COVID-19 infection;
    • have no knowledge of having been in contact with a confirmed case of COVID-19 during the 14 days prior to the flight;
    • agree to take an antigen test or a biological test on arrival;
    • agree to be reachable for no more than 15 days upon arrival in France and, if the result of a biological virological screening test taken on arrival in France confirms that they are infected with COVID-19, to remain in isolation for seven days after arrival in France and, if they are aged 11 or over, to take a biological virological screening test for SARS-CoV-2 at the end of this period.

 

PCR tests are taken on arrival in France since 1 January. All positive samples will be systematically sequenced for epidemiological surveillance purposes, and the persons concerned must comply with the applicable isolation rules.

NSpine newsletter Signup